- Home
- IMAB vs KFS Comparison
IMAB vs KFS Comparison
Compare IMAB & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- KFS
- Stock Information
- Founded
- IMAB 2014
- KFS 1989
- Country
- IMAB United States
- KFS United States
- Employees
- IMAB N/A
- KFS N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- IMAB Health Care
- KFS Finance
- Exchange
- IMAB Nasdaq
- KFS Nasdaq
- Market Cap
- IMAB 384.6M
- KFS 417.8M
- IPO Year
- IMAB 2020
- KFS 1996
- Fundamental
- Price
- IMAB $4.38
- KFS $14.02
- Analyst Decision
- IMAB Strong Buy
- KFS
- Analyst Count
- IMAB 4
- KFS 0
- Target Price
- IMAB $6.75
- KFS N/A
- AVG Volume (30 Days)
- IMAB 2.1M
- KFS 69.1K
- Earning Date
- IMAB 11-02-2025
- KFS 11-05-2025
- Dividend Yield
- IMAB N/A
- KFS N/A
- EPS Growth
- IMAB N/A
- KFS N/A
- EPS
- IMAB N/A
- KFS N/A
- Revenue
- IMAB N/A
- KFS $119,287,000.00
- Revenue This Year
- IMAB N/A
- KFS N/A
- Revenue Next Year
- IMAB N/A
- KFS N/A
- P/E Ratio
- IMAB N/A
- KFS N/A
- Revenue Growth
- IMAB N/A
- KFS 12.05
- 52 Week Low
- IMAB $0.60
- KFS $7.06
- 52 Week High
- IMAB $5.90
- KFS $16.80
- Technical
- Relative Strength Index (RSI)
- IMAB 54.65
- KFS 48.91
- Support Level
- IMAB $4.17
- KFS $13.91
- Resistance Level
- IMAB $4.69
- KFS $14.36
- Average True Range (ATR)
- IMAB 0.53
- KFS 0.35
- MACD
- IMAB -0.12
- KFS 0.00
- Stochastic Oscillator
- IMAB 25.44
- KFS 32.39
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.